Skip to main content
For research use only — not for human consumption
Elastin-derived peptide AGVPGLGVG original Regena research vial

Other · Putative elastin-derived nonapeptide

Elastin-derived peptide AGVPGLGVG

Also known as Ala-Gly-Val-Pro-Gly-Leu-Gly-Val-Gly

A glycine-rich nonapeptide labelled elastin-derived, requiring sequence-provenance checks and direct mechanistic characterisation.

Length
9 amino acids
Half-life
Not well characterised
Mechanism
A receptor-binding mechanism specific to isolated AGVPGLGVG is not well established. Its glycine-rich, largely non-polar sequence does not by itself demonstrate engagement of the elastin receptor complex, integrins or another matrix-recognition receptor.
Studied in
Sequence-controlled biophysical and in-vitro interaction assays can investigate AGVPGLGVG, although a well-established sequence-specific cellular or animal model is not documented.

About Elastin-derived peptide AGVPGLGVG

AGVPGLGVG is a nine-residue sequence containing four glycines, two valines, one alanine, one proline and one leucine. Its composition is compatible with a flexible, largely non-polar peptide, but composition alone cannot authenticate derivation from elastin. The stated origin should be supported by mapping to a specified parent sequence or by a documented fragment-identification study. A substantiated discovery account for this exact nonapeptide is not established from the sequence designation alone.

Mechanistic interpretation requires particular care because sequence order matters in elastin-fragment recognition. AGVPGLGVG does not contain the canonical GxxPG pattern associated with several elastin receptor-complex ligands, and similarity in amino acid composition is not equivalent to shared receptor activity. Research characterisation could combine solution-state measurements, stability testing and direct protein-binding assays. Any subsequent cellular observations should be evaluated with matched control peptides and receptor perturbation rather than assigned automatically to elastin-associated signalling.

Laboratory notes

  • Confirm the residue order by an appropriate sequence-sensitive analytical method where needed; intact mass alone cannot distinguish sequence isomers.
  • Assess solubility, aggregation and losses to laboratory surfaces under the actual assay conditions rather than assuming behaviour from composition.
  • Record terminal chemistry and verify parent-sequence provenance before comparing the material with other elastin-derived peptides.

Storage and reconstitution basics: storage guide.

Questions about Elastin-derived peptide AGVPGLGVG

Does AGVPGLGVG contain the canonical GxxPG motif?

No. It contains a VPG segment, but not the complete GxxPG pattern. This distinction prevents motif-based assumptions about elastin receptor-complex recognition.

Can its glycine-rich sequence establish an elastin origin?

No. Glycine-rich sequences occur in many proteins and synthetic constructs. Parent-protein mapping or direct fragment-identification evidence is required.

What would support a receptor-specific mechanism?

Reproducible direct binding, appropriate negative controls and loss of the relevant cellular response after receptor blockade or genetic perturbation would provide complementary evidence.

Is Elastin-derived peptide AGVPGLGVG for human use?

No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.

Related research peptides

All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.